Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Parkinson’s charity partners Biognosys on biomarker project

 April 15, 2026

Pharmaphorum

A new R D project will try to develop assays for LRRK2, a biomarker linked to Parkinson’s that has emerged as a major drug target in the disease.

M&A / DealsNeuroscienceRead full story

Post navigation

Daiichi exits OTC, with $1.55bn unit sale to Suntory →
← Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com